Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -539.92 Million USD | 4.94% |
| 2021 | -435.98 Million USD | -99.85% |
| 2020 | -275.69 Million USD | -4.79% |
| 2019 | -308.39 Million USD | -52.05% |
| 2018 | -147.09 Million USD | -302.67% |
| 2017 | 27.37 Million USD | 204.22% |
| 2016 | -60.33 Million USD | -941.33% |
| 2015 | -9.73 Million USD | 82.64% |
| 2014 | -31.54 Million USD | -54.88% |
| 2013 | -20.36 Million USD | -348.16% |
| 2012 | -4.55 Million USD | -47.97% |
| 2011 | -3.07 Million USD | -72.43% |
| 2010 | -1.78 Million USD | -92.01% |
| 2009 | -939.51 Thousand USD | -395.31% |
| 2008 | -187.28 Thousand USD | 30.79% |
| 2007 | -270.62 Thousand USD | 38.4% |
| 2006 | -439.28 Thousand USD | -42.61% |
| 2005 | -308.03 Thousand USD | -40271.04% |
| 2004 | -763.00 USD | 0.0% |
| 2003 | -763.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -85.3 Million USD | -13.63% |
| 2023 Q2 | -77.49 Million USD | 9.15% |
| 2022 Q4 | -75.06 Million USD | 29.65% |
| 2022 Q3 | -106.71 Million USD | -19.44% |
| 2022 FY | - USD | 4.94% |
| 2022 Q2 | -89.34 Million USD | 4.34% |
| 2022 Q1 | -93.39 Million USD | 7.67% |
| 2021 Q1 | 7.58 Million USD | 111.37% |
| 2021 Q2 | -162.1 Million USD | -2236.29% |
| 2021 Q3 | -85.15 Million USD | 47.47% |
| 2021 Q4 | -101.15 Million USD | -18.8% |
| 2021 FY | - USD | -99.85% |
| 2020 Q3 | -78.17 Million USD | -13.69% |
| 2020 FY | - USD | -4.79% |
| 2020 Q2 | -68.76 Million USD | -23.71% |
| 2020 Q1 | -55.58 Million USD | -7.54% |
| 2020 Q4 | -66.75 Million USD | 14.61% |
| 2019 Q2 | -46.02 Million USD | 51.47% |
| 2019 Q4 | -51.69 Million USD | 2.22% |
| 2019 FY | - USD | -52.05% |
| 2019 Q1 | -94.83 Million USD | -130.48% |
| 2019 Q3 | -52.86 Million USD | -14.87% |
| 2018 Q2 | -28.3 Million USD | 7.09% |
| 2018 Q4 | -41.14 Million USD | 4.77% |
| 2018 FY | - USD | -302.67% |
| 2018 Q1 | -30.46 Million USD | 59.5% |
| 2018 Q3 | -43.2 Million USD | -52.65% |
| 2017 Q3 | 94.99 Million USD | 850.89% |
| 2017 Q1 | -21.69 Million USD | -112.67% |
| 2017 FY | - USD | 204.22% |
| 2017 Q4 | -75.22 Million USD | -179.19% |
| 2017 Q2 | -12.65 Million USD | 41.69% |
| 2016 FY | - USD | -941.33% |
| 2016 Q2 | -44.12 Million USD | -151.57% |
| 2016 Q1 | -17.53 Million USD | 17.98% |
| 2016 Q3 | 14.53 Million USD | 132.95% |
| 2016 Q4 | -10.2 Million USD | -170.18% |
| 2015 Q2 | -9.92 Million USD | -6.15% |
| 2015 FY | - USD | 82.64% |
| 2015 Q3 | 35.19 Million USD | 454.42% |
| 2015 Q4 | -21.38 Million USD | -160.76% |
| 2015 Q1 | -9.35 Million USD | -29.36% |
| 2014 Q1 | -9.09 Million USD | 13.15% |
| 2014 FY | - USD | -54.88% |
| 2014 Q3 | -6.32 Million USD | 12.08% |
| 2014 Q2 | -7.19 Million USD | 20.92% |
| 2014 Q4 | -7.23 Million USD | -14.34% |
| 2013 Q3 | -2.99 Million USD | 33.24% |
| 2013 FY | - USD | -348.16% |
| 2013 Q1 | -2.4 Million USD | -44.39% |
| 2013 Q4 | -10.47 Million USD | -249.47% |
| 2013 Q2 | -4.48 Million USD | -86.31% |
| 2012 Q3 | -1.16 Million USD | -33.27% |
| 2012 FY | - USD | -47.97% |
| 2012 Q2 | -871.92 Thousand USD | -3.54% |
| 2012 Q1 | -842.15 Thousand USD | -19.33% |
| 2012 Q4 | -1.66 Million USD | -43.6% |
| 2011 Q1 | -669.38 Thousand USD | -269.95% |
| 2011 Q3 | -653.91 Thousand USD | 37.26% |
| 2011 FY | - USD | -72.43% |
| 2011 Q2 | -1.04 Million USD | -55.71% |
| 2011 Q4 | -705.72 Thousand USD | -7.92% |
| 2010 Q4 | -180.94 Thousand USD | 58.66% |
| 2010 Q1 | -594.22 Thousand USD | 12.87% |
| 2010 Q2 | -568.36 Thousand USD | 4.35% |
| 2010 Q3 | -437.66 Thousand USD | 23.0% |
| 2010 FY | - USD | -92.01% |
| 2009 Q3 | -225.19 Thousand USD | -183.88% |
| 2009 Q1 | -58.09 Thousand USD | -28.76% |
| 2009 FY | - USD | -395.31% |
| 2009 Q4 | -681.99 Thousand USD | -202.85% |
| 2009 Q2 | -79.32 Thousand USD | -36.55% |
| 2008 Q3 | -125.19 Thousand USD | -2203.86% |
| 2008 Q4 | -45.11 Thousand USD | 63.96% |
| 2008 Q2 | -5434.00 USD | 58.71% |
| 2008 Q1 | -13.16 Thousand USD | -77.41% |
| 2008 FY | - USD | 30.79% |
| 2007 Q3 | -10.64 Thousand USD | 15.69% |
| 2007 Q1 | -239.94 Thousand USD | 0.0% |
| 2007 FY | - USD | 38.4% |
| 2007 Q4 | -7418.00 USD | 30.28% |
| 2007 Q2 | -12.62 Thousand USD | 94.74% |
| 2006 FY | - USD | -42.61% |
| 2006 Q1 | - USD | 100.0% |
| 2005 Q3 | -191.00 USD | 0.0% |
| 2005 Q1 | -191.00 USD | -0.53% |
| 2005 FY | - USD | -40271.04% |
| 2005 Q4 | -307.45 Thousand USD | -160872.77% |
| 2005 Q2 | -191.00 USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | -191.00 USD | 0.0% |
| 2004 Q1 | -191.00 USD | 0.0% |
| 2004 Q3 | -191.00 USD | 0.0% |
| 2004 Q4 | -190.00 USD | 0.52% |
| 2003 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -180.981% |
| Alkermes plc | 495.04 Million USD | 209.066% |
| Agenus Inc. | -145.92 Million USD | -270.006% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -109.078% |
| Aptorum Group Limited | -9.59 Million USD | -5524.838% |
| Ardelyx, Inc. | -55.35 Million USD | -875.409% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -207.35% |
| Bicycle Therapeutics plc | -183.4 Million USD | -194.399% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -226.396% |
| ChromaDex Corporation | -3.89 Million USD | -13765.639% |
| Chimerix, Inc. | -92.97 Million USD | -480.73% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1115.05% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -379.791% |
| CRISPR Therapeutics AG | -202.7 Million USD | -166.367% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1585.063% |
| Dyadic International, Inc. | -8.22 Million USD | -6460.694% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -185442.268% |
| Fortress Biotech, Inc. | -133.64 Million USD | -304.008% |
| Lantern Pharma Inc. | -15.78 Million USD | -3320.147% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -598.095% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2611.517% |
| Incyte Corporation | 919.42 Million USD | 158.724% |
| IO Biotech, Inc. | -91.22 Million USD | -491.845% |
| Jaguar Health, Inc. | -33.13 Million USD | -1529.676% |
| Novavax, Inc. | -487.39 Million USD | -10.779% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -660.205% |
| Opthea Limited | -200.01 Million USD | -169.939% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 630.762% |
| ContextLogic Inc. | -324 Million USD | -66.644% |
| MiMedx Group, Inc. | 40.51 Million USD | 1432.596% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -587.868% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2904.031% |
| NextCure, Inc. | -59.03 Million USD | -814.528% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -5316.613% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 24257.852% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -841.036% |
| Vaxcyte, Inc. | -464.88 Million USD | -16.142% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1246.959% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -42.098% |
| Pharming Group N.V. | 9.87 Million USD | 5566.518% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2272.059% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -131.236% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2139.26% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2139.26% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -517.576% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1764.199% |
| Acelyrin, Inc. | -381.52 Million USD | -41.518% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -4190296.658% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 102165.784% |
| Summit Therapeutics Inc. | 1 Million USD | 54038.861% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1517.229% |
| Senti Biosciences, Inc. | -61.33 Million USD | -780.279% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -380.774% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -243.477% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1647.114% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -8727.335% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -168101.869% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1563.723% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -818.401% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -7743.231% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -621.685% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -19522.471% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -239.473% |
| Immix Biopharma, Inc. | -16.13 Million USD | -3246.182% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -254.803% |
| MEI Pharma, Inc. | 26.38 Million USD | 2146.732% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2578.347% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2174.818% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -3079.601% |
| Fortress Biotech, Inc. | -133.64 Million USD | -304.008% |
| Precigen, Inc. | -89.22 Million USD | -505.124% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2241.608% |
| AlloVir, Inc. | -190.14 Million USD | -183.954% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -342.191% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -213.494% |
| ImmuCell Corporation | -2.5 Million USD | -21461.957% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -313.989% |
| Onconetix, Inc. | -36.7 Million USD | -1370.924% |
| PureTech Health plc | -11.62 Million USD | -4543.743% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1745.403% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1202.067% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -6330.777% |
| Seer, Inc. | -97.88 Million USD | -451.594% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -768.093% |
| Innoviva, Inc. | 248.96 Million USD | 316.873% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -726.02% |
| ESSA Pharma Inc. | -26.45 Million USD | -1940.906% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1280.114% |
| GT Biopharma, Inc. | 5.97 Million USD | 9130.406% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -161.222% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -7761.503% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 721.951% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -851.348% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -954.156% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -5361.042% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -128.182% |
| Aptose Biosciences Inc. | -52.26 Million USD | -932.999% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -401.124% |
| Soligenix, Inc. | -7.85 Million USD | -6775.567% |
| Century Therapeutics, Inc. | -121.2 Million USD | -345.456% |
| Kura Oncology, Inc. | -164.95 Million USD | -227.318% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -574.084% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -5253.242% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -56275.276% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -12430.239% |
| Autolus Therapeutics plc | -156.77 Million USD | -244.408% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -537.783% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -682.493% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2608.578% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -185.264% |
| GRI Bio, Inc. | -10.89 Million USD | -4854.377% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11856.645% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -340.736% |
| IGM Biosciences, Inc. | -253.35 Million USD | -113.109% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -420.202% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1315.899% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3421.827% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3329.586% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -849.825% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -404.12% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -102.983% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -178.401% |
| Verastem, Inc. | -83.16 Million USD | -549.217% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -967.642% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -241.234% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -373.252% |
| Histogen Inc. | -10.5 Million USD | -5040.703% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3681.086% |
| Surrozen, Inc. | -41.13 Million USD | -1212.703% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3546.684% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16836021.422% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -819.603% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -952.614% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2406.746% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -6375.506% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -225.128% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -996.112% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -2134.246% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3486.361% |
| Apollomics, Inc. | -171.74 Million USD | -214.374% |
| Amarin Corporation plc | -50.9 Million USD | -960.73% |
| Mesoblast Limited | -61.33 Million USD | -780.351% |
| Turnstone Biologics Corp. | -56.23 Million USD | -860.145% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -277.042% |
| Synaptogenix, Inc. | -8.3 Million USD | -6399.278% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3419.969% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -756.39% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11168.535% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 125945.902% |
| Exelixis, Inc. | 196.6 Million USD | 374.63% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1311.134% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -281.82% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -9.03% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4477.346% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 218503.34% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1729.892% |
| Gritstone bio, Inc. | -126.86 Million USD | -325.599% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -730.85% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13398.382% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4602.796% |
| Insmed Incorporated | -654.73 Million USD | 17.535% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -23899.797% |
| MediWound Ltd. | -4.89 Million USD | -10934.703% |
| OmniAb, Inc. | -49.73 Million USD | -985.697% |
| Alector, Inc. | -142.89 Million USD | -277.857% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -531.983% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -935.376% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -1052.166% |
| Zai Lab Limited | -366.57 Million USD | -47.291% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -85.774% |
| Aura Biosciences, Inc. | -83.69 Million USD | -545.106% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -139.703% |
| Immunic, Inc. | -99.11 Million USD | -444.766% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -310.062% |
| Veracyte, Inc. | -49.4 Million USD | -992.773% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -7543.45% |
| FibroGen, Inc. | -261.4 Million USD | -106.548% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4746.315% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7611.794% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2784.714% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 137.251% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -2023.861% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1453.542% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2168.69% |
| Galecto, Inc. | -37.51 Million USD | -1339.079% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1311.023% |
| Fortrea Holdings Inc. | 167.3 Million USD | 422.73% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -302.091% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1807.132% |
| XBiotech Inc. | -35.76 Million USD | -1409.612% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -730.85% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -727.476% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -416.9% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2003.179% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1221.183% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -4.545% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -863.796% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -963179.87% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -364.115% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2335.448% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -129.694% |
| NexImmune, Inc. | -28.16 Million USD | -1816.847% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -9671.483% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4478.66% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 111.601% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -2026.371% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4509.589% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -329.039% |
| Ainos, Inc. | -8.77 Million USD | -6054.36% |
| Pluri Inc. | -20.22 Million USD | -2569.607% |
| Prothena Corporation plc | -190.1 Million USD | -184.011% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -321.167% |
| Celularity Inc. | -183.94 Million USD | -193.525% |
| Rallybio Corporation | -72.37 Million USD | -646.035% |
| Cue Biopharma, Inc. | -46.05 Million USD | -1072.431% |
| MeiraGTx Holdings plc | -57.05 Million USD | -846.379% |
| Omeros Corporation | -163.61 Million USD | -230.009% |
| Humacyte, Inc. | -96.45 Million USD | -459.755% |
| Immunocore Holdings plc | -59.64 Million USD | -805.175% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2687.157% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -2115.998% |
| Blueprint Medicines Corporation | -474.61 Million USD | -13.762% |
| CalciMedica, Inc. | -34.18 Million USD | -1479.245% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -637.264% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -330.232% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -220.525% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -113.926% |
| Pulmatrix, Inc. | -12.64 Million USD | -4169.556% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1537.833% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -510.316% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -6.639% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -433.447% |
| Cytokinetics, Incorporated | -456.68 Million USD | -18.228% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1517.859% |
| Nutriband Inc. | -5.12 Million USD | -10441.81% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1147.754% |
| Vor Biopharma Inc. | -114.37 Million USD | -372.085% |
| Roivant Sciences Ltd. | -996.51 Million USD | 45.818% |
| Evogene Ltd. | -23.2 Million USD | -2226.875% |
| ProKidney Corp. | -147.66 Million USD | -265.634% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -736.644% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -352450.784% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 4.517% |
| CorMedix Inc. | -48.88 Million USD | -1004.44% |
| BioLineRx Ltd. | -57.06 Million USD | -846.229% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -383.122% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -267191.089% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1386.954% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -579.01% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -564.012% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -95.979% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1656.435% |
| MediciNova, Inc. | -9.87 Million USD | -5364.875% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -328.715% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -35184.776% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1924.57% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -139.978% |
| Biomea Fusion, Inc. | -124.62 Million USD | -333.26% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -63.446% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1972.183% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -183.667% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -134.811% |
| Absci Corporation | -95.45 Million USD | -465.624% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1698.261% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -404.05% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -131.256% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2262.406% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -159.786% |
| Allakos Inc. | -189.91 Million USD | -184.3% |
| Imunon, Inc. | -19.87 Million USD | -2616.171% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -397.666% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 598.438% |
| BioAtla, Inc. | -122.24 Million USD | -341.691% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4477.346% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -3325.722% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -79.8% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1202.695% |
| XOMA Corporation | -39.36 Million USD | -1271.699% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -443.986% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -358.927% |
| aTyr Pharma, Inc. | -52.17 Million USD | -934.781% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -544.19% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -263.267% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -130.183% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3854.647% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6613.602% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3113.475% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 286221.268% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 219.467% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8351.396% |
| UroGen Pharma Ltd. | -63.83 Million USD | -745.871% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -695.006% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7333.941% |
| Orgenesis Inc. | -60.71 Million USD | -789.239% |
| Entera Bio Ltd. | -8.8 Million USD | -6032.758% |
| GH Research PLC | -41.15 Million USD | -1212.002% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -2015.788% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -556.583% |
| Xencor, Inc. | -125.87 Million USD | -328.943% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -37748.648% |
| Replimune Group, Inc. | -230.19 Million USD | -134.549% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2578.531% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4834.454% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8351.396% |
| Portage Biotech Inc. | -18.19 Million USD | -2866.8% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -35184.776% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -416.263% |
| OncoCyte Corporation | -23.12 Million USD | -2235.026% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4677.971% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4612.714% |
| Purple Biotech Ltd. | -22.22 Million USD | -2329.372% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -8323.214% |
| scPharmaceuticals Inc. | -46.06 Million USD | -1072.202% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2931.654% |
| HilleVax, Inc. | -132.46 Million USD | -307.597% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4977.852% |
| Tharimmune, Inc. | -9.3 Million USD | -5704.062% |
| Genprex, Inc. | -31.06 Million USD | -1638.307% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -187.922% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1622.039% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -70571.204% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 357895.685% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3428913.449% |
| Savara Inc. | -59.13 Million USD | -813.074% |
| Curis, Inc. | -45.13 Million USD | -1096.145% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1658.636% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3454.228% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -7435.632% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1919.63% |
| BeiGene, Ltd. | -1.12 Billion USD | 51.99% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -3212.198% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -25.395% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -497.662% |
| Erasca, Inc. | -121.31 Million USD | -345.081% |
| bluebird bio, Inc. | -167.16 Million USD | -222.999% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11901.718% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 274.011% |
| DBV Technologies S.A. | -85.98 Million USD | -527.955% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11901.718% |
| Moderna, Inc. | -3.28 Billion USD | 83.554% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1167.169% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -9459.632% |
| Molecular Templates, Inc. | 1.43 Million USD | 37857.203% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -802.105% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -65.497% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -293.852% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -1039.906% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -288.342% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -162.279% |
| MacroGenics, Inc. | 2.01 Million USD | 26868.865% |
| RenovoRx, Inc. | -11.39 Million USD | -4640.369% |
| Adicet Bio, Inc. | -136.53 Million USD | -295.45% |
| Prime Medicine, Inc. | -193.75 Million USD | -178.66% |
| Aditxt, Inc. | -25.45 Million USD | -2020.861% |
| Adagene Inc. | -14.95 Million USD | -3511.369% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7286.057% |
| Quantum-Si incorporated | -91.8 Million USD | -488.131% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 175.789% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 526.972% |
| SciSparc Ltd. | -5.28 Million USD | -10122.037% |
| Vericel Corporation | 2.86 Million USD | 18952.235% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -567003.605% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2389.131% |
| Generation Bio Co. | -133.3 Million USD | -305.047% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -550.281% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -527.655% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -137.4% |
| Invivyd, Inc. | -196.61 Million USD | -174.612% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -44.307% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5721.453% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 2088.392% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5149.665% |
| 2seventy bio, Inc. | -206.41 Million USD | -161.57% |
| ADMA Biologics, Inc. | 5.12 Million USD | 10645.469% |
| Clene Inc. | -43.24 Million USD | -1148.648% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2246.597% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -1013.782% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1924.57% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -80.237% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1370.018% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2390.451% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 11095.926% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1562.238% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -240.855% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 21.098% |
| Evaxion Biotech A/S | -21.4 Million USD | -2422.674% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -712.961% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -148.05% |
| Trevena, Inc. | -35.28 Million USD | -1430.061% |
| Surrozen, Inc. | -41.13 Million USD | -1212.703% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -578.37% |
| Cingulate Inc. | -22.95 Million USD | -2252.419% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -7136.671% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1348.188% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -6463.38% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -427.964% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -696.037% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -824.978% |
| Clearmind Medicine Inc. | -8.71 Million USD | -6098.472% |
| Kronos Bio, Inc. | -121.83 Million USD | -343.181% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -626.276% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -22015.381% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -435.499% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1486.744% |
| ImmunityBio, Inc. | -436.18 Million USD | -23.785% |
| Korro Bio, Inc. | -80.9 Million USD | -567.369% |
| Kineta, Inc. | -15.71 Million USD | -3335.968% |
| BioVie Inc. | -31.95 Million USD | -1589.904% |
| Codexis, Inc. | -49.28 Million USD | -995.566% |
| Celularity Inc. | -183.94 Million USD | -193.525% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -143.749% |
| Celcuity Inc. | -58.3 Million USD | -825.962% |
| Virax Biolabs Group Limited | -6.6 Million USD | -8069.409% |
| Cibus, Inc. | -314.58 Million USD | -71.632% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1500.593% |
| IN8bio, Inc. | -28.5 Million USD | -1794.218% |
| Kodiak Sciences Inc. | -259.02 Million USD | -108.448% |
| Annexon, Inc. | -141.57 Million USD | -281.372% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -379.514% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -741.062% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1831.418% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -134.741% |
| Eyenovia, Inc. | -24.1 Million USD | -2139.804% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1305.627% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -166544.444% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -631.57% |
| Arcellx, Inc. | -64.14 Million USD | -741.73% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1099.467% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -337.274% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1648.358% |
| Moolec Science SA | -52.07 Million USD | -936.817% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -946.25% |
| Geron Corporation | -174.78 Million USD | -208.915% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1235.893% |
| Royalty Pharma plc | 1.88 Billion USD | 128.609% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -351.471% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5690.576% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2503.222% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -225.101% |
| Humacyte, Inc. | -96.45 Million USD | -459.755% |
| Structure Therapeutics Inc. | -102.45 Million USD | -426.97% |
| 89bio, Inc. | -134.46 Million USD | -301.544% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -584.536% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 13424.975% |
| Genelux Corporation | -24.16 Million USD | -2134.339% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1497.42% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -230.304% |
| Notable Labs, Ltd. | -14.4 Million USD | -3649.5% |
| Liquidia Corporation | -70.05 Million USD | -670.764% |
| Mustang Bio, Inc. | -48.06 Million USD | -1023.376% |
| Immunovant, Inc. | -269.97 Million USD | -99.99% |
| Quantum-Si incorporated | -91.8 Million USD | -488.131% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -660.612% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2696.395% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -429.279% |
| Acasti Pharma Inc. | -11.3 Million USD | -4677.701% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2326.289% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3421.827% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -156.482% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -12543.668% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3300.05% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1776.314% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1358.083% |
| PepGen Inc. | -83.58 Million USD | -545.986% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1730.016% |
| United Therapeutics Corporation | 1.38 Billion USD | 138.933% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2258.073% |
| Solid Biosciences Inc. | -93.43 Million USD | -477.871% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -11215.127% |
| Immuneering Corporation | -58.06 Million USD | -829.935% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16836021.422% |
| Silo Pharma, Inc. | -3.62 Million USD | -14789.579% |
| Belite Bio, Inc | -31.52 Million USD | -1612.481% |
| XOMA Corporation | -39.36 Million USD | -1271.699% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -700.522% |
| Bionomics Limited | -9.83 Million USD | -5388.749% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -542.886% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1460.215% |
| uniQure N.V. | -253.1 Million USD | -113.326% |
| Cassava Sciences, Inc. | -95.68 Million USD | -464.265% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7286.057% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -316.92% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1562.494% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6606.786% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1813.349% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -166544.444% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4746.315% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3295.56% |
| Altimmune, Inc. | -87.93 Million USD | -514.008% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -486.375% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1460.215% |
| Compugen Ltd. | -12.51 Million USD | -4213.902% |
| Peak Bio, Inc. | -1356.23 USD | -39810846.521% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -1011.009% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2300.747% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -122.832% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1791.63% |
| Zura Bio Limited | -60.56 Million USD | -791.515% |
| PolyPid Ltd. | -20.26 Million USD | -2564.601% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3358.195% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1791.63% |
| Instil Bio, Inc. | -146.12 Million USD | -269.505% |
| argenx SE | -216.02 Million USD | -149.94% |
| Immunome, Inc. | -28.27 Million USD | -1809.83% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -1013.874% |
| Verona Pharma plc | -52.46 Million USD | -929.07% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -469.713% |
| Shattuck Labs, Inc. | -87.61 Million USD | -516.251% |
| CervoMed Inc. | -2.17 Million USD | -24760.006% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -341.681% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -4153.746% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1020.787% |
| Moolec Science SA | -52.07 Million USD | -936.817% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -3050.108% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -314.084% |
| AnaptysBio, Inc. | -143.16 Million USD | -277.14% |
| Design Therapeutics, Inc. | -66.32 Million USD | -714.064% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -566.685% |
| NeurAxis, Inc. | -6.66 Million USD | -8001.559% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1330.273% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1376.423% |
| Achilles Therapeutics plc | -70.44 Million USD | -666.486% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -469.713% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2339.357% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 9362.397% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -22015.381% |
| Nutriband Inc. | -5.12 Million USD | -10441.81% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -391.971% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -874.037% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -968.107% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -727.134% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -897.835% |
| Palisade Bio, Inc. | -12.28 Million USD | -4296.45% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1089.898% |
| Beam Therapeutics Inc. | -156.47 Million USD | -245.061% |
| Neurogene Inc. | -52.28 Million USD | -932.644% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -295.581% |
| AEON Biopharma, Inc. | -48.36 Million USD | -1016.453% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -480.455% |
| Sesen Bio, Inc. | -50.84 Million USD | -962.014% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -558.995% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -4271.878% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -26.319% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -413.254% |
| Athira Pharma, Inc. | -116.7 Million USD | -362.651% |
| Vaccinex, Inc. | -19.74 Million USD | -2634.09% |
| HCW Biologics Inc. | -23.57 Million USD | -2190.154% |
| XOMA Corporation | -39.36 Million USD | -1271.699% |
| Nektar Therapeutics | -243.1 Million USD | -122.095% |
| Arvinas, Inc. | -394.8 Million USD | -36.76% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 286221.268% |
| Merus N.V. | -149.2 Million USD | -261.865% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -477.525% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1627.217% |
| Rezolute, Inc. | -68.42 Million USD | -689.103% |
| Clene Inc. | -43.24 Million USD | -1148.648% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3400.981% |
| BeyondSpring Inc. | -21.54 Million USD | -2406.63% |
| Synlogic, Inc. | -55.16 Million USD | -878.822% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -4368.493% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4973.558% |
| Peak Bio, Inc. | -1356.23 USD | -39810846.521% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1563.108% |
| Krystal Biotech, Inc. | 17.9 Million USD | 3115.684% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -355.932% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -58.176% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -11621.176% |
| MannKind Corporation | 15.12 Million USD | 3668.828% |
| Ikena Oncology, Inc. | -74.39 Million USD | -625.739% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -4187.525% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2756.211% |
| Gossamer Bio, Inc. | -172.15 Million USD | -213.634% |
| CohBar, Inc. | -12.06 Million USD | -4374.878% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -2016.618% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1698.261% |
| Legend Biotech Corporation | -477.87 Million USD | -12.986% |
| Mural Oncology plc | -192.72 Million USD | -180.162% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -373.397% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3244.187% |
| Disc Medicine, Inc. | -91.02 Million USD | -493.165% |
| Champions Oncology, Inc. | -5.05 Million USD | -10583.182% |
| REGENXBIO Inc. | -239.46 Million USD | -125.474% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4937.494% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -868.376% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1292.706% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -378.634% |
| Vaxart, Inc. | -74.72 Million USD | -622.573% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1433.525% |
| Cellectis S.A. | -98.09 Million USD | -450.413% |
| Longeveron Inc. | -20.06 Million USD | -2591.565% |
| Repare Therapeutics Inc. | -114.27 Million USD | -372.49% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -22.936% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -621.713% |
| Revolution Medicines, Inc. | -430.58 Million USD | -25.395% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -8485.276% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1653.639% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -623.861% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 11112.197% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4824.104% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 111.724% |
| Denali Therapeutics Inc. | -179.97 Million USD | -200.005% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -567003.605% |
| Veru Inc. | -89.97 Million USD | -500.083% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1908.81% |
| Cingulate Inc. | -22.95 Million USD | -2252.419% |
| Passage Bio, Inc. | -98.34 Million USD | -449.037% |
| Context Therapeutics Inc. | -25.06 Million USD | -2054.492% |
| Exicure, Inc. | -15.53 Million USD | -3374.664% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -162.02% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1360.212% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -8955.25% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -220.501% |
| Nuvalent, Inc. | -149.49 Million USD | -261.175% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -6539.209% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -528.598% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1689.144% |
| OmniAb, Inc. | -49.73 Million USD | -985.697% |
| Anew Medical, Inc. | -1.3 Million USD | -41406.104% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -4266.936% |
| Lipocine Inc. | -16.32 Million USD | -3207.842% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -709.852% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -626.657% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1315.899% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1283.934% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2333.972% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 0.943% |
| Ocugen, Inc. | -64.82 Million USD | -732.875% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -483.265% |
| Q32 Bio Inc. | -86.5 Million USD | -524.18% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -3089.744% |
| Alumis Inc. Common Stock | -156.89 Million USD | -244.144% |
| Equillium, Inc. | -12.13 Million USD | -4348.245% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -823.396% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6731.636% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2762.673% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -1056.361% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -407.714% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2918.619% |
| Dominari Holdings Inc. | -22.44 Million USD | -2306.096% |
| Edesa Biotech, Inc. | -8.19 Million USD | -6492.413% |
| vTv Therapeutics Inc. | -25.41 Million USD | -2024.697% |
| Bio-Techne Corporation | 326.66 Million USD | 265.286% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -40.291% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 349.517% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -311.819% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1342.462% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -257.329% |
| Nkarta, Inc. | -120.48 Million USD | -348.144% |
| BioCardia, Inc. | -11.56 Million USD | -4570.657% |
| Iterum Therapeutics plc | -34.58 Million USD | -1461.388% |